CLINICAL_TRIALS
trial_result
· 2009-12-11
Clinical Trial Update: Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery [Phase 1]
Summary
Phase 1 trial evaluating riluzole for surgically resectable stage III or stage IV melanoma was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Melanoma (Skin) | Phase 1 | Status: TERMINATED